Home » Topics » Regulatory » Patents

Patents
RSS

New muscarinic acetylcholine M1 receptor allosteric agonists claimed

Oct. 13, 2011

Researchers at Astellas synthesize new serotonin 5-HT2C receptor agonists

Oct. 13, 2011

New cysteine and cystine prodrugs presented by Promentis Pharmaceuticals

Oct. 13, 2011

Kalypsys discloses novel histamine H4 receptor antagonists

Oct. 13, 2011

New York University prepares new anti-infective compounds

Oct. 13, 2011

Pulmagen Therapeutics reports novel neutrophil elastase inhibitors

Oct. 11, 2011

New JAK1 inhibitors claimed by Incyte

Oct. 11, 2011

Janssen Pharmaceutica presents new DPP-I inhibitors

Oct. 11, 2011

Pfizer synthesizes novel ghrelin receptor antagonists/inverse agonists

Oct. 11, 2011

New chemokine CCR3 receptor antagonists patented by Axikin Pharmaceuticals

Oct. 11, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...